U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

About this Database | Back to Search Page

Guidances | CFR

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with E

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
138009 Q2 2022 EDETATE DISODIUM INTRAVENOUS LIQUID 0.05 %w/v Correction
138010 Q3 2022 EDETATE DISODIUM INTRAVENOUS LIQUID 0.03 %w/v Correction
138099 Q3 2022 EDETATE TRISODIUM INTRAVENOUS INJECTION 0.37 %w/v Deletion
138233 Q2 2022 EDETATE DISODIUM TOPICAL CREAM, AUGMENTED 0.10 %w/w MDE Replacement
138234 Q3 2022 EDETATE DISODIUM TOPICAL CREAM, AUGMENTED 2mg MDE Replacement
138235 Q2 2022 ETHYL VANILLIN ORAL PASTE 0.22 mg/ 1.00 ml MDE Replacement
138236 Q3 2022 ETHYL VANILLIN ORAL PASTE 7mg MDE Replacement
138237 Q2 2022 ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B ORAL GRANULE, FOR SUSPENSION 10.62 mg MDE Replacement
138238 Q3 2022 ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B ORAL GRANULE, FOR SUSPENSION 21mg MDE Replacement
138239 Q2 2022 ETHYLPARABEN ORAL POWDER, FOR SOLUTION 0.66 mg/ 5.00 ml MDE Replacement
138240 Q3 2022 ETHYLPARABEN ORAL POWDER, FOR SOLUTION 13mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top